Skip to content

Efficacy and Safety of Laggera Pterodonta in Children aged <=24 months with acute bronchiolitis: a randomized controlled trial

Efficacy and Safety of Laggera Pterodonta in Children aged <=24 months with acute bronchiolitis: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002677
Enrollment
Unknown
Registered
2011-11-08
Start date
2012-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute bronchiolitis

Interventions

Intervention group:Laggera Pterodonta Mixture
Placebo:Placebo

Sponsors

The Second Affiliated Hospital of Kuming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 2 Years

Inclusion criteria

Inclusion criteria: 1. Admitted children aged 3~24 months clinically diagnosed as acute bronchiolitis with the first episode of wheezing from October 2012 to September 2013; 2. The clinical diagnosis of acute bronchiolitis must be followed by the standard diagnosis using the ICD-10 in J21 code; 3. Definition: Acute bronchiolitis is a viral lower respiratory tract infection in children under 2 years presenting with fever, coryza, cough, wheezing and/or crackles or respiratory distress.

Exclusion criteria

Exclusion criteria: 1. Those who had any chronic cardiopulmonary diseases such as congenital heart diseases, cystic fibrosis, bronchopulmonary dysplasia, or immunodeficiency; 2. Children who require ventilation support or continuous positive airway pressure (CPAP) will be excluded; 3. Children admitted into pediatric intensive care unit (PICU); 4. Children with pneumonia.

Design outcomes

Primary

MeasureTime frame
Proportion of children ready for discharge after 72 hours;

Secondary

MeasureTime frame
Pattern of clinical symptoms;Oxygen saturation comparision;frequency of adverse event;

Countries

China

Contacts

Public ContactXiaoling Xia
xxl5256@163.com+86 13908712443

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026